Very short vs. long dual antiplatelet therapy after second generation drug-eluting stents in 35 785 patients undergoing percutaneous coronary interventions: a meta-analysis of randomized controlled trials

被引:45
作者
Benenati, Stefano [1 ]
Galli, Mattia [2 ]
De Marzo, Vincenzo [1 ]
Pescetelli, Fabio [1 ]
Toma, Matteo [1 ]
Andreotti, Felicita [2 ,3 ]
Della Bona, Roberta [4 ]
Canepa, Marco [1 ,4 ]
Ameri, Pietro [1 ,4 ]
Crea, Filippo [2 ,3 ]
Porto, Italo [1 ,4 ]
机构
[1] Univ Genoa, Dipartimento Med Interna & Specialita Med DIMI, Viale Benedetto XV 6, I-16132 Genoa, Italy
[2] Univ Cattolica Sacro Cuore, Largo Francesco Vito 1, I-00168 Rome, Italy
[3] Fdn Policlin A Gemelli IRCCS, Dipartimento Sci Cardiovasc & Torac, Largo A Gemelli 8, I-00168 Rome, Italy
[4] Osped Policlin San Martino IRCCS, Dipartimento CardioToracoVasc, Largo Rosanna Benzi 10, I-16132 Genoa, Italy
关键词
Dual antiplatelet therapy; Very short; Long term; Acute coronary syndrome; Drug-eluting stent; FOCUSED UPDATE; CLOPIDOGREL; DURATION; IMPLANTATION; EVENTS; RISK; PCI; DISCONTINUATION; EFFICACY; SAFETY;
D O I
10.1093/ehjcvp/pvaa001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To provide an updated assessment of the efficacy-safety profile of very short (1 or 3 months) dual antiplatelet therapy (DAPT) compared with long (12 months) DAPT in patients undergoing percutaneous coronary interventions (PCIs). Methods and results Seven randomized controlled trials (RCTs) comparing very short vs. long DAPT in 35 785 patients undergoing PCI were selected. The primary efficacy endpoint was major adverse cardiovascular events (MACE) and the primary safety endpoint trial-defined major bleeding through at least 1 year. Compared with longer duration, very short DAPT yielded comparable rates of MACE [odds ratio (OR) 0.93, 95% confidence interval (CI) 0.84-1.03, P= 0.19], all-cause mortality (OR 0.92, 95% CI 0.80-1.06, P = 0.25), myocardial infarction (OR 1.01, 95% CI 0.88-1.15, P=0.91), stroke (OR 1.04, 95% CI 0.72-1.50, P= 0.83), stent thrombosis (OR 1.05, 95% CI 0.80-1.37, P=0.73), target vessel revascularization (OR 0.99, 95% CI 0.82-1.18, P= 0.89), and comparable net clinical benefit (OR 0.92, 95% CI 0.84-1.01, P= 0.08). Very short DAPT was associated with reduced rates of major bleeding (OR 0.61, 95% CI 0.40-0.94, P=0.03) or any bleeding (OR 0.65, 95% CI 0.47-0.90, P= 0.009). Subgroup analyses showed consistent results for 1 vs. 3 month DAPT and for aspirin vs. P2Y(12) inhibitor monotherapy following very short DAPT. Conclusion Compared with long DAPT, very short DAPT did not increase the odds of ischaemic complications, while reducing the odds of major or any bleeding by over 30%.
引用
收藏
页码:86 / 93
页数:8
相关论文
共 33 条
[1]  
[Anonymous], 2011, BMJ-BRIT MED J, DOI [DOI 10.1136/bmj.d5928, 10.1136/bmj.d5928]
[2]   Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial [J].
Aronow, Herbert D. ;
Steinhubl, Steven R. ;
Brennan, Danielle M. ;
Berger, Peter B. ;
Topol, Eric J. .
AMERICAN HEART JOURNAL, 2009, 157 (02) :369-374
[3]   Second-Generation Drug-Eluting Stent Implantation Followed by 6-Versus 12-Month Dual Antiplatelet Therapy The SECURITY Randomized Clinical Trial [J].
Colombo, Antonio ;
Chieffo, Alaide ;
Frasheri, Arian ;
Garbo, Roberto ;
Masotti-Centol, Monica ;
Salvatella, Neus ;
Dominguez, Juan Francisco Oteo ;
Steffanon, Luigi ;
Tarantini, Giuseppe ;
Presbitero, Patrizia ;
Menozzi, Alberto ;
Pucci, Edoardo ;
Mauri, Josepa ;
Cesana, Bruno Mario ;
Giustino, Gennaro ;
Sardella, Gennaro .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (20) :2086-2097
[4]   Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary Stenting [J].
Costa, Francesco ;
Van Klaveren, David ;
Feres, Fausto ;
James, Stefan ;
Raber, Lorenz ;
Pilgrim, Thomas ;
Hong, Myeong-Ki ;
Kim, Hyo-Soo ;
Colombo, Antonio ;
Steg, Philippe Gabriel ;
Bhatt, Deepak L. ;
Stone, Gregg W. ;
Windecker, Stephan ;
Steyerberg, Ewout W. ;
Valgimigli, Marco .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (07) :741-754
[5]   Final results of the randomised evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with a new-generation stent (REDUCE trial) [J].
De Luca, Giuseppe ;
Damen, Sander A. ;
Camaro, Cyril ;
Benit, Edouard ;
Verdoia, Monica ;
Rasoul, Saman ;
Liew, Houng Bang ;
Polad, Jawed ;
Ahmad, Wan A. ;
Zambahari, Robaayah ;
Postma, Sonja ;
Kedhi, Elvin ;
Suryapranata, Harry .
EUROINTERVENTION, 2019, 15 (11) :E990-+
[6]   6-Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin Final Results of the ITALIC Trial (Is There a Life for DES After Discontinuation of Clopidogrel) [J].
Didier, Romain ;
Morice, Marie Claude ;
Barragan, Paul ;
Noryani, Arif A. L. ;
Noor, Hussam A. ;
Majwal, Talib ;
Hovasse, Thomas ;
Castellant, Philippe ;
Schneeberger, Michel ;
Maillard, Luc ;
Bressolette, Erwan ;
Wojcik, Jaroslaw ;
Delarche, Nicolas ;
Blanchard, Didier ;
Jouve, Bernard ;
Ormezzano, Olivier ;
Paganelli, Franck ;
Levy, Gilles ;
Sainsous, Joel ;
Carrie, Didier ;
Furber, Alain ;
Berlan, Jacques ;
Darremont, Olivier ;
Le Breton, Herve ;
Lyuycx-Bore, Anne ;
Gommeaux, Antoine ;
Cassat, Claude ;
Kermarrec, Alain ;
Cazaux, Pierre ;
Druelles, Philippe ;
Dauphin, Raphael ;
Armengaud, Jean ;
Dupouy, Patrick ;
Champagnac, Didier ;
Ohlmann, Patrick ;
Ben Amer, Hakim ;
Kiss, Robert G. ;
Ungi, Irme ;
Gilard, Martine .
JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (12) :1202-1210
[7]   Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease [J].
Ellis, Stephen G. ;
Kereiakes, Dean J. ;
Metzger, D. Christopher ;
Caputo, Ronald P. ;
Rizik, David G. ;
Teirstein, Paul S. ;
Litt, Marc R. ;
Kini, Annapoorna ;
Kabour, Ameer ;
Marx, Steven O. ;
Popma, Jeffrey J. ;
McGreevy, Robert ;
Zhang, Zhen ;
Simonton, Charles ;
Stone, Gregg W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (20) :1905-1915
[8]   Three vs Twelve Months of Dual Antiplatelet Therapy After Zotarolimus-Eluting Stents The OPTIMIZE Randomized Trial [J].
Feres, Fausto ;
Costa, Ricardo A. ;
Abizaid, Alexandre ;
Leon, Martin B. ;
Marin-Neto, J. Antonio ;
Botelho, Roberto V. ;
King, Spencer B., III ;
Negoita, Manuela ;
Liu, Minglei ;
de Paula, J. Eduardo T. ;
Mangione, Jose A. ;
Meireles, George X. ;
Castello, Helio J., Jr. ;
Nicolela, Eduardo L., Jr. ;
Perin, Marco A. ;
Devito, Fernando S. ;
Labrunie, Andre ;
Salvadori, Decio, Jr. ;
Gusmao, Marcos ;
Staico, Rodolfo ;
Costa, J. Ribamar ;
de Castro, Juliana P. ;
Abizaid, Andrea S. ;
Bhatt, Deepak L. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (23) :2510-2522
[9]   Antithrombotic therapy in the early phase of non-ST-elevation acute coronary syndromes: a systematic review and meta-analysis [J].
Galli, Mattia ;
Andreotti, Felicita ;
D'Amario, Domenico ;
Vergallo, Rocco ;
Vescovo, Giovanni Maria ;
Giraldi, Luca ;
Migliaro, Stefano ;
Ameri, Pietro ;
Porto, Italo ;
Crea, Filippo .
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2020, 6 (01) :43-56
[10]   Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention The SMART-CHOICE Randomized Clinical Trial [J].
Hahn, Joo-Yong ;
Bin Song, Young ;
Oh, Ju-Hyeon ;
Chun, Woo Jung ;
Park, Yong Hawn ;
Jang, Woo Jin ;
Im, Eul-Soon ;
Jeong, Jin-Ok ;
Cho, Byung Ryul ;
Oh, Seok Kyu ;
Yun, Kyeong Ho ;
Cho, Deok-Kyu ;
Lee, Jong-Young ;
Koh, Young-Youp ;
Bae, Jang-Whan ;
Choi, JaeWoong ;
Lee, Wang Soo ;
Yoon, Hyuck Jun ;
Lee, Seung Uk ;
Cho, Jang Hyun ;
Choi, Woong Gil ;
Rha, Seung-Woon ;
Lee, Joo Myung ;
Park, Taek Kyu ;
Yang, Jeong Hoon ;
Choi, Jin-Ho ;
Choi, Seung-Hyuck ;
Lee, Sang Hoon ;
Gwon, Hyeon-Cheol ;
Kim, Dong-Bin ;
Cho, Sang Cheol ;
Hwang, Sun-Ho ;
Jeon, Dong Woon ;
Choi, Jae Woong ;
Ryu, Jae Kean ;
Kim, Moo-Hyun ;
Chae, In-Ho ;
Kim, Sang-Hyun ;
Kim, Hack-Lyoung ;
Cho, Jang Hyun ;
Jin, Dong Kyu ;
Suh, Il Woo ;
Park, Jong Seon ;
Shin, Eun-Seok ;
Kim, Shin-Jae ;
Cheong, Sang-Sig ;
Ho, Kyeong ;
Lee, Sung Yun ;
Chae, Jei Keon ;
Koh, Young Youp .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (24) :2428-2437